Results 151 to 160 of about 62,013 (267)

The Role of NLR, PLR, SII and CRP Pre- and Post-Treatment with Infliximab in Rheumatoid Arthritis. [PDF]

open access: yesBiomedicines
Rizaj D   +5 more
europepmc   +1 more source

Demyelinating polyneuropathy after long‐term treatment with infliximab [PDF]

open access: bronze, 2015
Keiko Nakamura   +2 more
openalex   +1 more source

Psoriasis Skin Clearance, Body Mass Index, and Lifestyle Behaviors

open access: yes
International Journal of Dermatology, EarlyView.
Annika Smith   +4 more
wiley   +1 more source

Machine learning methods for predicting adverse drug events: A systematic review

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 422-444, February 2026.
Abstract Predicting adverse drug events (ADEs) in outpatient settings is crucial for improving medication safety, identifying high‐risk patients and reducing health‐care costs. While traditional methods struggle with the complexity of health‐care data, machine learning (ML) models offer improved prediction capabilities; however, their effectiveness in ...
Niaz Chalabianloo   +8 more
wiley   +1 more source

Steroid-sparing strategies for managing immune-related adverse events. [PDF]

open access: yesJ Immunother Cancer
Huang JJ   +4 more
europepmc   +1 more source

The Association Between Serum Immunoglobulin G Titers Against Porphyromonas gingivalis and Chronic Kidney Disease in Patients With Rheumatoid Arthritis and Periodontitis: A Retrospective Cohort Study

open access: yesClinical and Experimental Dental Research, Volume 12, Issue 1, February 2026.
ABSTRACT Objectives Chronic kidney disease (CKD) is relatively common in patients with rheumatoid arthritis (RA). Periodontitis and periodontopathic Porphyromonas gingivalis are risk factors for CKD. However, the association of serum immunity to P. gingivalis and its peptidylarginine deiminase (PPAD), as well as periodontitis severity, with CKD in ...
Tetsuo Kobayashi   +5 more
wiley   +1 more source

Safety outcomes in 2132 Danish patients with inflammatory arthritis treated with biosimilar infliximab (GP1111) in routine care. [PDF]

open access: yesTher Adv Musculoskelet Dis
Nabi H   +18 more
europepmc   +1 more source

Engagement and retention with remote monitoring in psoriasis: Findings from the mySkin study

open access: yes
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Weiyu Ye   +22 more
wiley   +1 more source

Home - About - Disclaimer - Privacy